2008 Industry Almanac, Jun 15, 2008 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

2008 Industry Almanac, Jun 15, 2008
Industry Resources
Industry Events for 2008–2009
This section from PharmTech's 2008 Industry Almanac features upcoming events for 2008 and 2009.
Approved New Molecular Entities
This section lists the approved new molecular entities from Jan. 2007 through May 2008. The company names, brand names, indications and molecular structures are included.
Top 50 Manufacturing Pharmaceutical Companies
This list of the top 50 pharmaceutical companies for 2007 is based on global sales. It includes each company's 2007 sales and shows the change from 2006.
Industry and Trade Associations
This section provides contact information for important industry and trade associations worldwide.
Regulatory, Governmental & Standards Organizations
This section provides contact information for important regulatory, governmental and standards organizations worldwide.
Industry Employment Factoids
See statistics from Pharmaceutical Technology's annual employment survey and how those compare with national trends.
Pharmaceutical Technology Article Index
The magazine's articles (June 2007 to June 2008) are listed by type and topic.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here